Literature DB >> 8897812

ET-1 induces IL-6 gene expression in human umbilical vein endothelial cells: synergistic effect of IL-1.

J Stankova1, P D'Orléans-Juste, M Rola-Pleszczynski.   

Abstract

Endothelins are a family of potent vasoactive peptides that have also been implicated in inflammation. To examine the consequence of endothelin stimulation on cytokine production, we explored the effect of endothelin-1 (ET-1) on interleukin-6 (IL-6) gene expression. ET-1 augmented the production of IL-6 in human umbilical vein endothelial cells (HUVEC) by 2- to 5-fold and synergized with IL-1 to induce a 150-fold increase in IL-6 secretion, compared with spontaneous production. The peak of IL-6 production was in the presence of 100 pM ET-1 after 12 h of stimulation. ET-1 augmented IL-6 mRNA expression at the optimal concentration of 100 pM, in the presence of 1 ng/ml of IL-1. ET-1-induced IL-6 mRNA expression was significant within 4 h of stimulation and persisted for 18 h. Similarly, the ETB receptor-specific agonist, IRL-1620, also augmented IL-6 mRNA expression and IL-6 protein production in HUVEC. Our results suggest that endothelin may play a role at the vascular inflammatory site by modulating cytokine production through ETB receptor activation in endothelial cells of human origin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897812     DOI: 10.1152/ajpcell.1996.271.4.C1073

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Endothelin-1-induced endothelial microvesicles impair endothelial cell function.

Authors:  L Madden Brewster; Vinicius P Garcia; Ma'ayan V Levy; Kelly A Stockelman; Anabel Goulding; Noah M DeSouza; Jared J Greiner; Jamie G Hijmans; Christopher A DeSouza
Journal:  J Appl Physiol (1985)       Date:  2020-04-23

Review 2.  Endothelin-1 as a target for therapeutic intervention in prostate cancer.

Authors:  E Scott Kopetz; Joel B Nelson; Michael A Carducci
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

Review 3.  Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.

Authors:  Brandon M Fox; Malgorzata Kasztan
Journal:  Life Sci       Date:  2016-04-03       Impact factor: 5.037

4.  Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation.

Authors:  A P Piovezan; P D'Orléans-Juste; G E Souza; G A Rae
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

5.  Inhibitory effects of Syzygium jambos extract on biomarkers of endothelial cell activation.

Authors:  Yaritza Inostroza-Nieves; Shirley Valentin-Berrios; Christopher Vega; Gregory N Prado; Claribel Luciano-Montalvo; José R Romero; Alicia Rivera
Journal:  BMC Complement Med Ther       Date:  2022-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.